Production (Stage)
PureTech Health plc
PRTC
$18.20
-$0.80-4.21%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 334.15% | 334.15% | -67.07% | -67.07% | -84.88% |
Total Depreciation and Amortization | -6.14% | -6.14% | -40.74% | -40.74% | -59.30% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -809.13% | -809.13% | 48.99% | 48.99% | 79.08% |
Change in Net Operating Assets | -56.44% | -56.44% | -911.34% | -911.34% | 71.17% |
Cash from Operations | -33.28% | -33.28% | -22.85% | -22.85% | 55.45% |
Capital Expenditure | -- | -- | -- | -- | 100.00% |
Sale of Property, Plant, and Equipment | -75.64% | -75.64% | -68.14% | -68.14% | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 191.18% | 191.18% | 26.28% | 26.28% | -5.37% |
Cash from Investing | 104.17% | 104.17% | 36.02% | 36.02% | -4.54% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -10.93% | -10.93% | 6.58% | 6.58% | 29.45% |
Issuance of Common Stock | -100.00% | -100.00% | -6.87% | -6.87% | -40.92% |
Repurchase of Common Stock | 91.02% | 91.02% | -1,363.00% | -1,363.00% | 44.32% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -31.88% | -31.88% | 100.00% |
Cash from Financing | 260.97% | 260.97% | -142.55% | -142.55% | 43.07% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 82.54% | 82.54% | -41.49% | -41.49% | 26.20% |